| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
Glycominds Ltd. Product Pipeline Analysis
Summary
This report is an insightful source for data, analysis and strategic insights
into a Glycominds Ltd.'s pipeline and investigational products. The report
also provides details on clinical trials covering trial phase, description,
investigator information, primary and secondary end-points and trial results
for products in development.
Scope
• Details of development stage by sector and equipment type.
• Pipeline
products grouped by therapy area, development stage and trial phase.
•
Detailed information on clinical trials covering trial phase, description,
investigator .nformation, primary and secondary end-points and trial
results.
• Trial updates, trial start and end dates, patient numbers and
the trials primary outcome measures, secondary outcome measures.
• Product
updates covering estimated approval dates and estimated launch dates.
•
Descriptions of novel technologies relating to pipeline products of the
company.
• Patents and patent applications covered for the product.
•
News updates on key events relating to the product and its development.
Reasons to buy
• A single source to fulfill competitor information relating to products in
development.
• Identify pipeline products that are potential competitor to
your product lines.
Understand a company's strategic position by accessing
detailed independent intelligence on its product pipeline.
• Access
clinical trial information to map trial results and plan targeted marketing
activities.
• Take corrective measures on your own development programs
and R&D initiatives based on regulatory events of competitor product
pipelines.
• Identification of potential investment opportunities.
•
Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets
you keep track of market potential build for a new product.
Assess a
company's future growth by determining its pipeline depth, for probable
acquisition opportunities.
TABLE OF CONTENTS
1 Table of Contents 3
1.1 List Of Tables 5
1.2 List of Figures 6
2
Company Overview 7
2.1 Key Information 7
2.2 Financial Performance
7
2.3 Industry Outlook -- In Vitro Diagnostics 7
3 Major Products and
Services 8
3.1 Overview 8
4 Competitors 9
5 Key Employees 10
6
Locations And Subsidiaries 11
6.1 Head Office 11
6.2 Other Locations &
Subsidiaries 11
7 Recent Developments 12
7.1 Product News 12
7.1.1
Sep 25, 2007: Glycominds Joins Biomolecular Photonic Consortium To Develop New
Molecular Imaging Technique 12
8 Glycominds Ltd. Pipeline Products 13
8.1 Glycominds Ltd. Product Pipeline Analysis 13
8.1.1 Glycominds Ltd.
Pipeline Products By Equipment Type 13
8.1.2 Glycominds Ltd. Pipeline
Products By Development Stage 14
8.1.3 Glycominds Ltd. Pipeline Products
By Therapy Area 15
8.1.4 Glycominds Ltd. Pipeline Products By News Summary
15
8.2 IBDX serological assay for Crohn's disease 15
8.2.1 Product
Description 15
8.2.2 Product Status 15
8.2.3 Product Milestone 16
8.3 gMS Dx 16
8.3.1 Product Description 16
8.3.2 Product Status 16
8.4 gMS PRO 17
8.4.1 Product Description 17
8.4.2 Product Status
17
8.5 Blood test for breast cancer 17
8.5.1 Product Description
17
8.5.2 Product Status 18
8.6 Blood test for colorectal cancer 18
8.6.1 Product Description 18
8.6.2 Product Status 18
8.7 Blood Test
For Prediction Of Recurrent Pregnancy Loss 18
8.7.1 Product Description
18
8.7.2 Product Status 19
9 Appendix 20
9.1 Methodology 20
9.1.1 Coverage 20
9.1.2 Secondary Research 21
9.1.3 Primary Research
21
9.1.4 Expert Panel Validation 22
9.2 Contact Us 22
9.3 About
Global Markets Direct 22
9.4 Disclaimer 22
1.1 List Of Tables
Table 1: Glycominds Ltd.,Key Facts 7
Table 2: Glycominds Ltd.,
Key Employees, 10
Table 3: Glycominds Ltd., Other Locations 11
Table 4: Glycominds Ltd. Pipeline Products by Equipment Type 13
Table
5: Glycominds Ltd. Pipeline Products By Development Stage 14
Table 6:
Glycominds Ltd. Pipeline Products By Therapy Area 15
Table 7:
Glycominds Ltd. Pipeline Products By News Summaries 15
1.2 List of
Figures
Figure 1: Glycominds Ltd. Pipeline Products By Development
Stage 14
Figure 2: Global Markets Direct Methodology 20
|
